BRIVIACT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Mexico, Netherlands, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug BRIVIACT contains one active pharmaceutical ingredient (API):

1	Brivaracetam UNII U863JGG2IA - BRIVARACETAM
	Brivaracetam displays a high and selective affinity for synaptic vesicle protein 2A (SV2A), a transmembrane glycoprotein found at presynaptic level in neurons and in endocrine cells. Although the exact role of this protein remains to be elucidated it has been shown to modulate exocytosis of neurotransmitters.
	Read more about Brivaracetam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BRIVIACT Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AX23		N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX23

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11327E, 11328F, 11334M, 11338R, 11339T, 11349H, 11350J, 11356Q, 11357R, 11358T
EE	Ravimiamet	1708781, 1708792, 1708804, 1708815, 1708826, 1708837, 1708848, 1708859, 1708860, 1708871, 1708882, 1708893, 1708905, 1708916, 1708927, 1708938, 1708949, 1708950, 1708961, 1708972, 1709018, 1709029, 1849710, 1849721
ES	Centro de información online de medicamentos de la AEMPS	1151073006, 1151073010, 1151073014, 1151073018, 1151073021, 1151073022
FI	Lääkealan turvallisuus- ja kehittämiskeskus	144024, 157197, 388813, 460137, 486271, 525456, 560527
FR	Base de données publique des médicaments	60579228, 63546596, 64002423, 64065772, 64872342, 65519142, 67429003
GB	Medicines & Healthcare Products Regulatory Agency	314998, 315007, 315014, 315024, 315029, 315075, 319281, 367630, 367632, 367634, 374315, 374317, 374319, 376227, 376229, 377163, 381223, 381225, 381227, 391520, 391522
HK	Department of Health Drug Office	65938, 65939, 65940, 65941, 65942, 65943
IE	Health Products Regulatory Authority	44021, 44022, 44023, 44024, 44026, 44027, 44029
IL	מִשְׂרַד הַבְּרִיאוּת	8359, 8361, 8362, 8363, 8364, 8465
LT	Valstybinė vaistų kontrolės tarnyba	1079518, 1079519, 1079520, 1079521, 1079522, 1079523, 1079524, 1079525, 1079526, 1079527, 1079528, 1079529, 1079531, 1079532, 1079533, 1079534, 1079535, 1079536, 1079537, 1079538, 1079539, 1079540, 1080494, 1080495, 1080496, 1080497, 1080498
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	379M2016, 386M2016
NL	Z-Index G-Standaard, PRK	131954, 131962, 131970, 131989, 131997, 132004
PL	Rejestru Produktów Leczniczych	100368820, 100368837, 100368843, 100368850, 100368866, 100368872, 100368889
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63823001, W63824001, W63825001, W63826001, W63827001, W63828001, W63829001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699624090188, 8699624090195, 8699624090201, 8699624090218, 8699624090225, 8699624090232, 8699624090249, 8699624090256, 8699624090263, 8699624090270, 8699624090287, 8699624090294, 8699624090300, 8699624090317, 8699624090324, 8699624650085, 8699624770011
US	FDA, National Drug Code	50474-370, 50474-470, 50474-570, 50474-670, 50474-770, 50474-870, 50474-970